Try our Advanced Search for more refined results

Move For Interlocutory Appeal Denied In Reglan Case

By Ryan Davis (April 14, 2009, 12:00 AM EDT) -- Generics makers including Teva Pharmaceuticals USA Inc. and Barr Pharmaceuticals LLC have lost their bid for an interlocutory appeal of a ruling denying their motions for summary judgment in a failure-to-warn suit over generic versions of Wyeth Inc.'s heartburn drug Reglan, arguing unsuccessfully that the claims in the suit are preempted by federal law....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!